12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of the pathology would have a ...

12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of the pathology would have a ...

The most exciting breakthrough is Adaptive Deep Brain Stimulation (aDBS), which reduces Parkinson’s symptoms by up to 50%. While earlier DBS devices gave the brain continuous electrical stimulation, ...

Blarcamesine is a sigma 1 receptor agonist which targets Alzheimer's pathology upstream of amyloid and tau pathology, ...

Parkinson's disease is an illness that affects the part of your brain that controls how you move your body. Some people with Parkinson’s first notice weakness, difficulty walking, and stiff ...

A natural antioxidant found in foods like kale and berries, kaempferol, may help protect nerve cells and shows promise as a ...

On World Autism Awareness Day (April 2nd), speaking in my 90 Second Statement, I said “too many senior Public Officials in Wales still rely ...

Trontinemab is currently being studied in the Phase Ib/IIa Brainshuttle AD study assessing the safety, tolerability, ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical ...

Scientists at Johns Hopkins Medicine say they have discovered how a group of proteins linked to Parkinson's disease and amyotrophic lateral sclerosis act as "guardians" of mitochondria, small ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data were presented at the AD/PD 2025 International Conference on Alzheimer's and Parkinson's Diseases in ...